POXEL (EPA:POXEL) | Finanzwire

Basculer en Français

8396	Companies
122097	Keywords
60577	Articles
65553	Press releases

Home
Companies
POXEL

BRIEF

published on 12/09/2024 at 07:35, 12 days 11 hours ago

Poxel Announces Financial Challenges and Outlines Future Strategy

Financial Results General Meeting Bonds Redemption Cash Runway Poxel SA
PRESS RELEASE

published on 12/09/2024 at 07:30, 12 days 11 hours ago

Inside Information / News release on accounts, results
Poxel reports financial results for first half 2024 including revenue of EUR 1.162 million and net loss of EUR 7.258 million, provides outlook following non-adoption of financial delegations at AGM, upcoming General Meeting to adopt new resolutions

Financial Results Revenue Outlook General Meeting Poxel
BRIEF

published on 11/29/2024 at 07:35, 22 days 11 hours ago

Poxel Combined General Meeting: Results and Decisions

Shareholders Resolutions Financial Communication General Assembly Poxel
PRESS RELEASE

published on 11/29/2024 at 07:30, 22 days 11 hours ago

Inside Information / Other news releases
Poxel announces successful Annual General Meeting results, including voting statistics and approved resolutions. Details available on the company's website

Annual General Meeting Financial Statements Voting Results Metabolic Disorders Poxel
BRIEF

published on 11/04/2024 at 20:10, 1 month 16 days ago

Evolution of the number of shares and voting rights of Poxel in 2024

Share Capital Voting Rights Actions AMF Biopharmaceutical
BRIEF

published on 10/11/2024 at 07:35, 2 months 10 days ago

Poxel Releases 2023 Universal Registration Document

Corporate Governance Annual Financial Report CSR Report Poxel 2023 Registration Document
PRESS RELEASE

published on 10/11/2024 at 07:30, 2 months 10 days ago

Annual financial and audit reports / Terms of availability of the annual financial report
Poxel announces availability of the 2023 Universal Registration Document including financial and governance reports, now filed with the AMF

AMF Biopharmaceutical Company Financial Report Universal Registration Document Poxel
BRIEF

published on 10/03/2024 at 18:35, 2 months 18 days ago

Poxel announces its financial and strategic results for 2023

Financial Results Biopharmaceutical TWYMEEG® Poxel OrbiMed
BRIEF

published on 09/30/2024 at 07:35, 2 months 21 days ago

Poxel Secures $50M Non-Dilutive Financing from OrbiMed

Non-dilutive Financing TWYMEEG® Poxel Royalty Monetization OrbiMed
PRESS RELEASE

published on 09/30/2024 at 07:30, 2 months 21 days ago

Inside Information / Other news releases
Poxel monetizes TWYMEEG® royalties in a USD 50 million deal with OrbiMed. Proceeds to reduce debt and support rare disease activities. Webinars scheduled for investor updates

Webinars Royalties TWYMEEG® Poxel OrbiMed

Accesswire

Published on 12/21/2024 at 01:30, 17 hours 42 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 42 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours 7 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 19 hours 12 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 42 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

EQS Group

Published on 12/21/2024 at 00:51, 18 hours 21 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 27 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 1 day ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

ARYZTA AG Announces New Board Technology Committee

Les Echos

Published on 12/21/2024 at 12:17, 6 hours 54 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 1 day 5 hours ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 2 days ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE